Evidence map›Paper›PMID 38379184›Full record

ArticleAnnals of neurology2024

Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes.

Zoe Arvanitakis, Ana W Capuano, Han Tong, Rupal I Mehta, Frederick Anokye-Danso, David A Bennett, Steven E Arnold, Rexford S Ahima

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zoe ArvanitakisRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Ana W CapuanoRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Han TongRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.ORCID 0000-0002-9821-5928
Rupal I MehtaRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Frederick Anokye-DansoDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Steven E ArnoldAlzheimer's Clinical and Translational Research Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Rexford S AhimaDepartment of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.
Rush University Medical Center · USJohns Hopkins University · USHarvard University · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
Linking peripheral and brain insulin resistance to AD neuropathology and cognitionRF1AG059621 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI AHIMA, REXFORD S., ARNOLD, STEVEN E · 2018 to 2018
$3.8M
The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black personsRF1AG074549 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI ARVANITAKIS, ZOE · 2021 to 2021
$3.3M
Mechanisms linking insulin resistance to brain structure, pathology, and functionR01NS084965 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI AHIMA, REXFORD S., ARNOLD, STEVEN E · 2014 to 2018
$3.2M
The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black personsR01AG074549 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI ARVANITAKIS, ZOE · 2024 to 2025
$2.2M
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS P30AG072975NIA NIH HHS P30AG10161NIA NIH HHS R01 AG017917NIA NIH HHS R01AG017917NIA NIH HHS R01 AG074549NIA NIH HHS RF1 AG059621NIA NIH HHS RF1AG059621NIA NIH HHS RF1 AG074549NIA NIH HHS RF1AG074549NINDS NIH HHS R01 NS084965NINDS NIH HHS R01NS084965
6 · The paper itself

Abstract

objectiveTo examine associations of serum insulin and related measures with neuropathology and cognition in older persons.

methodsWe studied 192 older persons (96 with diabetes and 96 without, matched by sex and balanced by age-at-death, education, and postmortem interval) from a community-based, clinical-pathologic study of aging, with annual evaluations including neuropsychological testing (summarized into global cognition and 5 cognitive domains) and postmortem autopsy. We assessed serum insulin, glucose, leptin, adiponectin, hemoglobin A1C, advanced glycation-end products (AGEs), and receptors for advanced glycation-end products, and calculated the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and adiponectin-to-leptin ratio. Using adjusted regression analyses, we examined the associations of serum measures with neuropathology of cerebrovascular disease and Alzheimer's disease, and with the level of cognition proximate-to-death.

resultsHigher HOMA-IR was associated with the presence of brain infarcts and specifically microinfarcts, and higher HOMA-IR and leptin were each associated with subcortical infarcts. Further, higher leptin levels and lower adiponectin-to-leptin ratios were associated with the presence of moderate-to-severe atherosclerosis. Serum insulin and related measures were not associated with the level of Alzheimer's disease pathology, as assessed by global, as well as amyloid burden or tau tangle density scores. Regarding cognitive outcomes, higher insulin and leptin levels, and lower adiponectin and receptors for advanced glycation-end products levels, respectively, were each associated with lower levels of global cognition.

interpretationPeripheral insulin resistance indicated by HOMA-IR and related serum measures was associated with a greater burden of cerebrovascular neuropathology and lower cognition. ANN NEUROL 2024;95:665-676.

Indexed as

Alzheimer DiseaseDiabetes MellitusInsulin ResistanceNervous System DiseasesAdiponectinAgedAged, 80 and overCognitionHumansInsulinLeptinAdiponectinInsulinLeptin

Identifiers

PMID38379184
PMCPMC11023784
OpenAlexW4392002283

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.